Quadrant Clinical Care Logo

INNOVATIVE MEDICAL TREATMENTS AT GLOBAL CLINICS

Quadrant Clinical Care-Antigua provides hemoperfusion blood filter treatment to patients diagnosed with Cancer and Blood Stream Infections (BSI). Utilizing the ONCOBind and the Seraph® 100 Microbind® Blood Filters, the clinically evaluated treatment is safe. The medical team on the island includes licensed physicians, nurses, and specialists, all of whom provide a high level of care. While research and results are ongoing, early results support safety and effectiveness, offering hope and potentially improved quality of life to the patients treated. To learn more, please complete the form, and a member of our concierge care team will contact you.

Antigua
Quadrant Clinical Care Filter

HEMOPERFUSION BLOOD FILTER TREATMENT

Quadrant Clinical Care is an authorized distributor for the ONCObind Extracorporeal and Seraph® 100 Microbind® Affinity Blood Filters from ExThera Medical.

The ONCObind and Seraph® 100 Microbind® Affinity Blood Filters are single-use broad-spectrum extracorporeal hemoperfusion devices designed to remove circulating tumor cells and treat bloodstream infections by binding pathogens from the blood.1,2,3 As blood flows through the filters, it passes over microbeads coated with molecular heparin receptor sites that mimic the heparan sulfate receptors on human cells that pathogens attack when invading the body. These harmful pathogens, which include bacteria, viruses, fungi, circulating cancer cells and other disease-causing molecules, bind to the Seraph beads and are removed from the bloodstream without negatively impacting the blood cells or proteins.3

The Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100) is available in the US under FDA EUA #200165 and indicated for ICU COVID-19 treatment. Please refer to https://www.fda.gov/media/137105/download for additional information.

The ONCOBind Extracorporeal Blood Filter is FDA approved for Investigational Device Exemption (IDE). Learn more here.

  1. Seraph 100 Microbind Affinity Blood Filter Instructions For Use: CP021 Rev A FDA EUA200165
  2. Olson SW, Oliver JD, Collen J, et al. Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter. Crit Care Explor. 2020;2(8):e0180. Published 2020 Jul 30. doi:10.1097/CCE.0000000000000180
  3. Seffer MT, Cottam D, Forni LG, Kielstein JT. Heparin 2.0: A New Approach to the Infection Crisis. Blood Purif. 2021;50:28-34. doi: 10.1159/000508647

    Full website coming May 2024.

    © 2024 Quadrant Clinical Care